학술논문
Clinicopathological Features and Outcomes of Progression for Chronic Lymphocytic Leukaemia (CLL) Treated with the BCL2 Inhibitor Venetoclax
Document Type
Abstract
Author
Source
In Blood 2 December 2016 128(22):3223-3223
Subject
Language
ISSN
0006-4971